Covestor LTD Fibrogen Inc Transaction History

Covestor LTD

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$0.79 - $2.83 $23 - $84	30 Added 333.33%	39 $0
Q4 2022 Feb 13, 2023	SELL	$13.27 - $17.73 $79 - $106	-6 Reduced 40.0%	9 $0
Q3 2022 Nov 14, 2022	SELL	$11.4 - $14.6 $22 - $29	-2 Reduced 11.76%	15 $0
Q2 2022 Aug 10, 2022	SELL	$7.94 - $12.96 $39 - $64	-5 Reduced 22.73%	17 $0
Q1 2022 May 13, 2022	BUY	$12.02 - $16.79 $264 - $369	22 New	22 $0
Q4 2021 Feb 10, 2022	BUY	$9.93 - $15.39 $0 - $0	0 New	0 $0

47.1M

387K

672K

Ticker FGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 93,741,200
Market Cap $32.8M
Description
FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing Roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases, which has completed Phase III clinical development for the treatment of anemia in chronic k...

Get notified when there are updates to the investment portfolio of Covestor LTD, based on Form 13F filings with the SEC.

Stay updated on Covestor LTD with notifications on news.